Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

342
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
342
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

575
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
575
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

304
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

615
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
615
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

405
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

510
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
510

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Changing Landscape of Journalology in Medicine.

Seminars in nuclear medicine·2019
Same author

Systematic reviews in restorative dentistry: discussing relevant aspects.

Journal of esthetic and restorative dentistry : official publication of the American Academy of Esthetic Dentistry ... [et al.]·2019
Same author

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2019
Same author

Guidance for reporting outcomes in clinical trials: scoping review protocol.

BMJ open·2019
Same author

Systematic reviews in dentistry: Current status, epidemiological and reporting characteristics.

Journal of dentistry·2019
Same author

Screening for depression in women during pregnancy or the first year postpartum and in the general adult population: a protocol for two systematic reviews to update a guideline of the Canadian Task Force on Preventive Health Care.

Systematic reviews·2019

Related Experiment Video

Updated: Mar 6, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K

Do systematic reviews on pediatric topics need special methodological considerations?

Mufiza Farid-Kapadia1, Lisa Askie2, Lisa Hartling3

  • 1Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.

BMC Pediatrics
|March 7, 2017
PubMed
Summary

Pediatric systematic reviews face unique challenges. This study identifies these issues and proposes a new checklist to improve the quality and reporting of child health systematic reviews.

Keywords:
MethodsPediatricsReporting guidelineSystematic reviews

More Related Videos

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

18.8K
Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.7K

Related Experiment Videos

Last Updated: Mar 6, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

18.8K
Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.7K

Area of Science:

  • Child Health Research
  • Evidence Synthesis
  • Systematic Review Methodology

Background:

  • Systematic reviews are crucial for healthcare decisions but face challenges in pediatric research.
  • Existing guidelines like PRISMA do not fully address pediatric-specific methodological issues.
  • Uncertainty in pediatric systematic reviews hinders effective decision-making in child health.

Purpose of the Study:

  • To identify methodological challenges unique to pediatric systematic reviews.
  • To propose a process for addressing these challenges in the design, conduct, and reporting of pediatric systematic reviews.
  • To develop a consensus-based checklist for planning and reporting pediatric systematic reviews.

Main Methods:

  • Identification of pediatric-specific methodological challenges in systematic reviews.
  • Proposal of a process to address these challenges.
  • Development of a consensus-based checklist (PRISMA-PC and PRISMA-C) for pediatric systematic reviews.

Main Results:

  • Key challenges include defining pediatric populations, selecting appropriate comparators, and using validated outcomes.
  • Lack of pediatric-sensitive search strategies and inconsistent age subgroup definitions in meta-analyses were identified.
  • The study proposes new reporting standards tailored for pediatric systematic reviews.

Conclusions:

  • Standardized approaches are needed to overcome methodological hurdles in pediatric systematic reviews.
  • The proposed checklist will enhance the transparency and quality of pediatric systematic reviews.
  • Improved systematic reviews will facilitate knowledge translation, enhancing child health outcomes and care delivery.